Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
Wada et al., Frontiers in Medicine, doi:10.3389/fmed.2023.1139046
https://c19ivm.org/wada.html